$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

$sfes Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000143774920023173 Filed on November 09, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.200M	$2.100M	$2.300M
YoY Change	-42.86%	-8.7%	-34.29%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$1.200M	$2.100M	$2.300M
YoY Change	-42.86%	-8.7%	-34.29%
Operating Profit	-$1.631M	-$2.275M	-$2.262M
YoY Change	-20.83%	0.57%	-35.67%
Interest Expense	-$3.000M	-$1.200M	-$9.000M
YoY Change	233.33%	-86.67%	-124.52%
% of Operating Profit
Other Income/Expense, Net	-$663.0K	-$820.0K	$8.777M
YoY Change	-129.53%	-109.34%	-914.19%
Pretax Income	-$7.353M	-$4.343M	-$2.497M
YoY Change	953.44%	73.93%	-107.79%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$7.353M	-$4.343M	-$2.497M
YoY Change	953.44%	73.93%	-107.79%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.35	-$0.21	-$0.12
Diluted Earnings Per Share	-$0.35	-$0.21	-$0.12
COMMON SHARES
Basic Shares Outstanding	20.89M	20.79M	20.66M
Diluted Shares Outstanding		20.79M	20.66M

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$15.60M	$16.40M	$45.00M
YoY Change	-37.6%	-63.56%	-35.34%
Cash & Equivalents	$15.60M	$16.40M	$45.04M
Short-Term Investments			$0.00
Other Short-Term Assets	$500.0K	$600.0K	$3.300M
YoY Change	-61.54%	-81.82%	57.14%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$16.06M	$17.01M	$48.33M
YoY Change	-39.04%	-64.81%	-33.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.790M	$1.869M	$2.174M
YoY Change	-14.8%	-14.03%	68.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$27.82M	$30.71M	$35.26M
YoY Change	-19.46%	-12.92%	-50.81%
Other Assets	$784.0K	$1.368M	$702.0K
YoY Change	-60.74%	94.87%	122.15%
Total Long-Term Assets	$52.97M	$59.08M	$82.52M
YoY Change	-34.79%	-28.4%	-21.64%
TOTAL ASSETS
Total Short-Term Assets	$16.06M	$17.01M	$48.33M
Total Long-Term Assets	$52.97M	$59.08M	$82.52M
Total Assets	$69.04M	$76.09M	$130.8M
YoY Change	-35.83%	-41.85%	-26.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$56.00K	$36.00K	$117.0K
YoY Change	43.59%	-69.23%	588.24%
Accrued Expenses	$410.0K	$531.0K	$1.138M
YoY Change	-34.61%	-53.34%	-48.58%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$3.470M	$2.611M	$3.708M
YoY Change	42.86%	-29.58%	-86.92%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$637.0K	$1.109M	$1.728M
YoY Change	-37.97%	-35.82%	-44.37%
Total Long-Term Liabilities	$637.0K	$1.109M	$1.728M
YoY Change	-37.97%	-35.82%	-44.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.470M	$2.611M	$3.708M
Total Long-Term Liabilities	$637.0K	$1.109M	$1.728M
Total Liabilities	$6.160M	$5.859M	$7.912M
YoY Change	5.55%	-25.95%	-91.66%
SHAREHOLDERS EQUITY
Retained Earnings	-$736.6M	-$729.3M	-$675.8M
YoY Change	5.65%	7.91%	-5.41%
Common Stock	$809.7M	$811.3M	$812.8M
YoY Change	-0.4%	-0.18%	-0.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$10.20M	$11.81M	$14.00M
YoY Change	-27.27%	-15.66%	-8.41%
Treasury Stock Shares	$688.0K	$789.0K	928.0K shares
Shareholders Equity	$62.90M	$70.20M	$122.9M
YoY Change
Total Liabilities & Shareholders Equity	$69.04M	$76.09M	$130.8M
YoY Change	-35.83%	-41.85%	-26.63%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q3
OPERATING ACTIVITIES
Net Income	-$7.353M	-$4.343M	-$2.497M
YoY Change	953.44%	73.93%	-107.79%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$1.100M	-$1.200M	-$6.300M
YoY Change	-26.67%	-80.95%	26.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$300.0K	$4.000M	$23.00M
YoY Change	-81.25%	-82.61%	-2.54%
Cash From Investing Activities	$300.0K	$4.000M	$23.00M
YoY Change	-81.25%	-82.61%	-2.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	-44.60M
YoY Change	-100.0%	-100.0%
NET CHANGE
Cash From Operating Activities	-1.100M	-1.200M	-6.300M
Cash From Investing Activities	300.0K	4.000M	23.00M
Cash From Financing Activities	0.000	0.000	-44.60M
Net Change In Cash	-800.0K	2.800M	-27.90M
YoY Change	-96.12%	-110.04%	-250.0%
FREE CASH FLOW
Cash From Operating Activities	-$1.100M	-$1.200M	-$6.300M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20893063
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-4343000	USD
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20657000
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000
CY2020Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	789000
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	930000
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0.0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0.0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0.0	USD
CY2019	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0
CY2019Q1	sfe	Preferred Stock Purchase Right To Be Exchanged For Common Stock Above Maximum Ownership Threshold PreferredStockPurchaseRightToBeExchangedForCommonStockAboveMaximumOwnershipThreshold	1
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16437000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	70229000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25028000	USD
CY2020Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	USD
CY2019Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	25000	USD
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	570000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1297000	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	17007000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	26350000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1869000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2101000	USD
CY2020Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	55844000	USD
CY2019Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	77129000	USD
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1368000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1997000	USD
CY2020Q3	us-gaap	Assets Assets	76088000	USD
CY2019Q4	us-gaap	Assets Assets	107577000	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	36000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	39000	USD
CY2020Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1706000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1364000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	531000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	627000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	338000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	399000	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2611000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2429000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2139000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2380000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1109000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1027000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	5859000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	5836000	USD
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	2157000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	2157000	USD
CY2020Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	809189000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	810856000	USD
CY2020Q3	us-gaap	Treasury Stock Value TreasuryStockValue	11806000	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	14024000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-729286000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-697223000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-820000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	101741000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	76088000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	107577000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2275000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2262000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7835000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7922000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2275000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2262000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7835000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7922000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8777000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7045000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10010000	USD
CY2020Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	52000	USD
CY2019Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	234000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	209000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1870000	USD
CY2020Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	-0	USD
CY2019Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	5806000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	-0	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	14023000	USD
CY2020Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1300000	USD
CY2019Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3440000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-15591000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	65324000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4343000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2497000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-30262000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	55259000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-4343000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-2497000	USD
	us-gaap	Profit Loss ProfitLoss	-30262000	USD
	us-gaap	Profit Loss ProfitLoss	55259000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.46
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.68
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.46
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.68
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20786000
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20657000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20731000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20623000
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20786000
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20657000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20731000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20623000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20731000
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-2497000	USD
	us-gaap	Profit Loss ProfitLoss	-30262000	USD
	us-gaap	Profit Loss ProfitLoss	55259000	USD
CY2020Q3	sfe	Other Comprehensive Income Loss Share Of Other Comprehensive Income Loss Of Equity Method Investments OtherComprehensiveIncomeLossShareOfOtherComprehensiveIncomeLossOfEquityMethodInvestments	0	USD
CY2019Q3	sfe	Other Comprehensive Income Loss Share Of Other Comprehensive Income Loss Of Equity Method Investments OtherComprehensiveIncomeLossShareOfOtherComprehensiveIncomeLossOfEquityMethodInvestments	0	USD
	sfe	Other Comprehensive Income Loss Share Of Other Comprehensive Income Loss Of Equity Method Investments OtherComprehensiveIncomeLossShareOfOtherComprehensiveIncomeLossOfEquityMethodInvestments	0	USD
	sfe	Other Comprehensive Income Loss Share Of Other Comprehensive Income Loss Of Equity Method Investments OtherComprehensiveIncomeLossShareOfOtherComprehensiveIncomeLossOfEquityMethodInvestments	-31000	USD
CY2020Q3	sfe	Other Comprehensive Income Loss Reclassification Adjustment On Sale Of Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentOnSaleOfEquityMethodInvestments	0	USD
CY2019Q3	sfe	Other Comprehensive Income Loss Reclassification Adjustment On Sale Of Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentOnSaleOfEquityMethodInvestments	0	USD
	sfe	Other Comprehensive Income Loss Reclassification Adjustment On Sale Of Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentOnSaleOfEquityMethodInvestments	0	USD
	sfe	Other Comprehensive Income Loss Reclassification Adjustment On Sale Of Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentOnSaleOfEquityMethodInvestments	6000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-4343000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2497000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-30262000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	55234000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7025000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18543000	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	7587000	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	101190000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	7510000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	9500000	USD
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	1638000	USD
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	4954000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	-0	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	57243000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	95189000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1561000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	124682000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	-0	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	68568000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	30000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	210000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-30000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-68778000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-8616000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	37361000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25053000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8203000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16437000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45564000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	101741000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-16008000	USD
CY2020Q1	sfe	Stock Issued During Period Value Restricted Stock Award Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes	72000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	85808000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-9911000	USD
CY2020Q2	sfe	Stock Issued During Period Value Restricted Stock Award Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes	72000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	146000	USD
CY2020Q2	sfe	Cumulative Effect Of Change In Accounting At Ownership Interests CumulativeEffectOfChangeInAccountingAtOwnershipInterests	-1801000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	74314000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-4343000	USD
CY2020Q3	sfe	Stock Issued During Period Value Restricted Stock Award Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes	73000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	185000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	70229000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	66979000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	21663000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2019Q1	sfe	Stock Issued During Period Value Restricted Stock Award Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes	-149000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	417000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-31000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	88879000	USD
CY2019Q2	us-gaap	Profit Loss ProfitLoss	36093000	USD
CY2019Q2	sfe	Stock Issued During Period Value Restricted Stock Award Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes	-31000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	269000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	6000	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	125216000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-2497000	USD
CY2019Q3	sfe	Stock Issued During Period Value Restricted Stock Award Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes	-30000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	248000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	122937000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16400000	USD
CY2020Q3	us-gaap	Equity Method Investments EquityMethodInvestments	30707000	USD
CY2019Q4	us-gaap	Equity Method Investments EquityMethodInvestments	34542000	USD
CY2020Q3	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	20438000	USD
CY2019Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	27484000	USD
CY2020Q3	us-gaap	Advances To Affiliate AdvancesToAffiliate	4699000	USD
CY2019Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	15103000	USD
CY2020Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	55844000	USD
CY2019Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	77129000	USD
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	1500000	USD
CY2020Q3	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-500000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	936000	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	452000	USD
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	248000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	979000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	934000	USD
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	79000
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	30000
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0.0	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-4343000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-2497000	USD
	us-gaap	Profit Loss ProfitLoss	-30262000	USD
	us-gaap	Profit Loss ProfitLoss	55259000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20786000
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20657000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20731000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20623000
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.46
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.68
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-4343000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-2497000	USD
	us-gaap	Profit Loss ProfitLoss	-30262000	USD
	us-gaap	Profit Loss ProfitLoss	55259000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20786000
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20657000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20731000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20623000
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	0
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	0
	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	0
	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	0
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20786000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20623000
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.46
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.68
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	200000
CY2020Q3	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	1500000	USD
CY2020Q3	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	900000	USD
	sfe	Employee And Severance Agreement Maximum Aggregate Exposure EmployeeAndSeveranceAgreementMaximumAggregateExposure	2500000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	170000	USD
CY2020Q3	sfe	Lessee Subleaseexpected Receipts Remainder Of Fiscal Year LesseeSubleaseexpectedReceiptsRemainderOfFiscalYear	129000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	595000	USD
CY2020Q3	sfe	Lessee Sublease Expected Receipts Year One LesseeSubleaseExpectedReceiptsYearOne	525000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	601000	USD
CY2020Q3	sfe	Lessee Subleaseexpected Receipts Year Two LesseeSubleaseexpectedReceiptsYearTwo	540000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	607000	USD
CY2020Q3	sfe	Lessee Subleaseexpected Receipts Year Three LesseeSubleaseexpectedReceiptsYearThree	556000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	613000	USD
CY2020Q3	sfe	Lessee Subleaseexpected Receipts Year Four LesseeSubleaseexpectedReceiptsYearFour	573000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	619000	USD
CY2020Q3	sfe	Lessee Subleaseexpected Receipts Year Five LesseeSubleaseexpectedReceiptsYearFive	590000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	208000	USD
CY2020Q3	sfe	Lessee Subleaseexpected Receipts Thereafter LesseeSubleaseexpectedReceiptsThereafter	199000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3413000	USD
CY2020Q3	sfe	Lessee Sublease Expected Receipts Total LesseeSubleaseExpectedReceiptsTotal	3112000	USD
CY2015Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	25000000.0	USD
CY2019Q1	sfe	Sale Of Stock Individual Ownership Percent Maximum SaleOfStockIndividualOwnershipPercentMaximum	0.0499	pure
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2477000	USD

Files In Submission

Name	View Source	Status
0001437749-20-023173-index-headers.html	Edgar Link	pending
0001437749-20-023173-index.html	Edgar Link	pending
0001437749-20-023173.txt	Edgar Link	pending
0001437749-20-023173-xbrl.zip	Edgar Link	pending
ex_201438.htm	Edgar Link	pending
ex_201439.htm	Edgar Link	pending
ex_201440.htm	Edgar Link	pending
ex_201441.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sfe-20200930.xsd	Edgar Link	pending
sfe-20200930_cal.xml	Edgar Link	unprocessable
sfe-20200930_def.xml	Edgar Link	unprocessable
sfe-20200930_lab.xml	Edgar Link	unprocessable
sfe-20200930_pre.xml	Edgar Link	unprocessable
sfe20200930_10q.htm	Edgar Link	pending
sfe20200930_10q_htm.xml	Edgar Link	completed
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

2020 Q4 Form 10-Q Financial Statement

#000143774920023173 Filed on November 09, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES SAFEGUARD SCIENTIFICS INC Stock $sfes

2020 Q4 Form 10-Q Financial Statement

#000143774920023173 Filed on November 09, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes